Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Publication year range
1.
Seizure ; 95: 75-80, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35016147

ABSTRACT

PURPOSE: To evaluate the diagnostic utility of serum prolactin (PRL) and lactate (LAC) concentrations for patients presenting with either or both convulsions and transient loss of consciousness (TLOC) in the emergency room (ER). METHODS: This was a retrospective single-center study conducted in a tertiary care hospital ER. Medical records of consecutive patients who presented with convulsions or TLOC between January 2018 and December 2020 were reviewed. Patients with an ER diagnosis of epileptic seizures, psychogenic non-epileptic seizure (PNES), and syncope were selected for analysis. Serum PRL and LAC concentrations were measured within 3 h of the event and compared between groups. RESULTS: Among the 440 eligible patients, 173 (39.3%) were included for analysis. Serum PRL concentration was significantly higher in patients with epileptic seizures with convulsions than in those with PNES with convulsions (p < 0.001) and convulsive syncope (p = 0.023). Serum LAC concentration was not significantly elevated in patients with convulsive syncope. Using a PRL cut-off value of 24.0 ng/mL, serum PRL concentration had 100.0% sensitivity and 82.9% specificity for differentiating between PNES and other attacks without convulsions. CONCLUSION: Elevated serum PRL with normal serum LAC concentration in patients who have attacks with convulsions suggests convulsive syncope. Serum PRL concentration is useful in the diagnosis of PNES with convulsions. However, serum LAC concentration is not useful as a routine screening test for attacks without convulsions in the ER.


Subject(s)
Lactic Acid , Prolactin , Diagnosis, Differential , Electroencephalography , Emergency Service, Hospital , Humans , Retrospective Studies , Seizures/diagnosis
3.
Epilepsy Behav ; 97: 161-168, 2019 08.
Article in English | MEDLINE | ID: mdl-31252273

ABSTRACT

OBJECTIVES: The objectives of this study were to determine how hemispheric laterality of seizure activity influences periictal heart rate variability (HRV) and investigate the ability of HRV parameters to discriminate right- and left-sided seizures. METHODS: Long-term video electroencephalogram-electrocardiogram recordings of 54 focal seizures in 25 patients with focal epilepsy were reviewed. Using linear mixed models, we examined the effect of seizure laterality on linear (standard deviation of R-R intervals [SDNN], root mean square of successive differences [RMSSD], low frequency [LF] and high frequency [HF] power of HRV, and LF/HF) and nonlinear (standard deviation [SD]1, SD2, and SD2/SD1 derived from Poincaré plots) periictal HRV parameters, the magnitude of heart rate (HR) changes, and the onset time of increased HR. Receiver operating characteristics (ROC) were used to determine the ability of these parameters to discriminate between right- and left-sided seizures. RESULTS: Postictal SDNN, RMSSD, LF, HF, SD1, and SD2 were higher in right- than left-sided seizures. Root mean square of successive difference and HF were decreased after left- but not right-sided seizures. Standard deviation of R-R intervals, LF, and SD1 were increased after right- but not left-sided seizures. Increased ictal HR was earlier and larger in right- than left-sided seizures. Postictal HF showed the greatest area under the ROC curve (AUC) (0.87) for discriminating right- and left-sided seizures. CONCLUSIONS: Our data suggest that postictal parasympathetic activity is higher, whereas ictal HR increase is greater, in right- than left-sided seizures. Involvement of the right hemisphere may be associated with postictal autonomic instability. Postictal HRV parameters may provide useful information on hemispheric laterality of seizure activity.


Subject(s)
Autonomic Nervous System Diseases/physiopathology , Epilepsies, Partial/physiopathology , Heart Rate/physiology , Seizures/physiopathology , Adolescent , Adult , Aged , Electrocardiography , Electroencephalography , Female , Humans , Linear Models , Male , Middle Aged , ROC Curve , Retrospective Studies , Video Recording , Young Adult
6.
Sci Rep ; 6: 22991, 2016 Mar 10.
Article in English | MEDLINE | ID: mdl-26961412

ABSTRACT

Epilepsy is a frequent comorbidity in patients with focal cortical dysplasia (FCD). Recent studies utilizing massive sequencing data identified subsets of genes that are associated with epilepsy and FCD. AKT and mTOR-related signals have been recently implicated in the pathogenic processes of epilepsy and FCD. To clarify the functional roles of the AKT-mTOR pathway in the hippocampal neurons, we generated conditional knockout mice harboring the deletion of Pten (Pten-cKO) in Proopiomelanocortin-expressing neurons. The Pten-cKO mice developed normally until 8 weeks of age, then presented generalized seizures at 8-10 weeks of age. Video-monitored electroencephalograms detected paroxysmal discharges emerging from the cerebral cortex and hippocampus. These mice showed progressive hypertrophy of the dentate gyrus (DG) with increased expressions of excitatory synaptic markers (Psd95, Shank3 and Homer). In contrast, the expression of inhibitory neurons (Gad67) was decreased at 6-8 weeks of age. Immunofluorescence studies revealed the abnormal sprouting of mossy fibers in the DG of the Pten-cKO mice prior to the onset of seizures. The treatment of these mice with an mTOR inhibitor rapamycin successfully prevented the development of seizures and reversed these molecular phenotypes. These data indicate that the mTOR pathway regulates hippocampal excitability in the postnatal brain.


Subject(s)
Epilepsies, Partial/genetics , Epilepsy/genetics , Malformations of Cortical Development/genetics , PTEN Phosphohydrolase/genetics , Pro-Opiomelanocortin/genetics , TOR Serine-Threonine Kinases/genetics , Animals , Craniofacial Abnormalities , Dentate Gyrus/growth & development , Dentate Gyrus/pathology , Disease Models, Animal , Electroencephalography , Epilepsies, Partial/drug therapy , Epilepsies, Partial/pathology , Epilepsy/drug therapy , Epilepsy/pathology , Hippocampus/drug effects , Hippocampus/growth & development , Hippocampus/pathology , Humans , Malformations of Cortical Development/drug therapy , Malformations of Cortical Development/pathology , Mice , Mice, Knockout , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Pro-Opiomelanocortin/biosynthesis , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction/drug effects , Sirolimus/administration & dosage , TOR Serine-Threonine Kinases/antagonists & inhibitors
7.
Rinsho Shinkeigaku ; 56(2): 108-11, 2016.
Article in Japanese | MEDLINE | ID: mdl-26754594

ABSTRACT

We report the case of a 17-year-old woman with paroxysmal sympathetic storm (PSS), which was successfully treated with clonidine hydrochloride. The patient was hospitalized for acute disseminated encephalomyelitis in June 2006. Dysphagia led to severe aspiration pneumonia in September 2006, and she suffered cardiopulmonary arrest. She survived but had severe brain damage, with her brain MRI showing diffuse hypoxic encephalopathy. From October 2006, she had several episodes of profound tachypnea (> 60/min), tachycardia (160 to 170 beats/min), hypertension (> 140 mmHg), hyperthermia (39°C), and decerebrate posturing. During the attacks, the levels of catecholamines in the patient's blood and urine were markedly elevated. Accordingly, a diagnosis of PSS associated with hypoxic encephalopathy was made. Her PSS clearly improved after the administration of clonidine hydrochloride (900 µg/day). This case suggests that clonidine hydrochloride, an α2 blocker, may be one therapeutic option for PSS.


Subject(s)
Autonomic Nervous System Diseases/drug therapy , Autonomic Nervous System Diseases/etiology , Clonidine/therapeutic use , Encephalomyelitis, Acute Disseminated/complications , Encephalomyelitis, Acute Disseminated/drug therapy , Hypoxia, Brain/drug therapy , Hypoxia, Brain/etiology , Adolescent , Autonomic Nervous System Diseases/diagnosis , Biomarkers/blood , Catecholamines/blood , Female , Humans , Treatment Outcome
8.
Rinsho Shinkeigaku ; 55(1): 37-40, 2015.
Article in Japanese | MEDLINE | ID: mdl-25672864

ABSTRACT

A 44-year-old man with a bilateral hand tremor suffered from a decline in concentration and abnormal vision for several months. He also complained of easily falling down because of muscle stiffness and cramps in his lower limbs. On admission, he demonstrated lower limb stiffness, muscle cramps, diplopia, hyperhidrosis, left upper limb ataxia and dysesthesia in all limbs. Laboratory examination showed a marked elevation in his serum creatine kinase level (26,890 U/l), and needle electromyography demonstrated myokymic discharges in the muscles of his lower extremities. Isaacs' syndrome was diagnosed based on a positive voltage-gated potassium channel antibody titer of 1,007 pM. Administration of an anticonvulsant (phenytoin, 200 mg/day) did not resolve his symptoms; however, high-dose intravenous methylprednisolone therapy (1 g/day for 3 days) resulted in marked clinical improvement. This case suggests that high-dose intravenous methylprednisolone therapy for Isaacs' syndrome might be as effective as other immunosuppressive therapies such as plasma exchange or intravenous immunoglobulin.


Subject(s)
Glucocorticoids/administration & dosage , Isaacs Syndrome/diagnosis , Isaacs Syndrome/drug therapy , Methylprednisolone/administration & dosage , Adult , Autoantibodies/blood , Biomarkers/blood , Creatine Kinase/blood , Electromyography , Humans , Infusions, Intravenous , Isaacs Syndrome/immunology , Isaacs Syndrome/pathology , Magnetic Resonance Imaging , Male , Muscle, Skeletal/pathology , Potassium Channels, Voltage-Gated/immunology , Pulse Therapy, Drug , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL